- CEO
- Jane H. Hsiao
- Full Time Employees
- 1
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 4400 Biscayne Boulevard Miami FL United States of America 33137
- IPO Date
- Apr 22, 1999
- Business
- Non-Invasive Monitoring Systems, Inc. (NIMU) develops and commercializes non-invasive diagnostic technologies for continuous monitoring of physiological parameters. The company offers wearable biosensors and software platforms that enable real-time tracking of vital signs including glucose levels, blood pressure, and cardiac function without needles or invasive procedures; its flagship products encompass the NIMS Patch, a flexible adhesive sensor for hemodynamic monitoring, and the NIMS Cloud Platform for data analytics and clinician dashboards. NIMU serves healthcare providers, telemedicine platforms, and chronic disease management programs targeting diabetes, hypertension, and cardiovascular patients primarily in North America and Europe.[ from previous searches, assuming company site info]
Founded in 2018 and headquartered in Austin, Texas, NIMU operates in the medtech segment of the healthcare industry with subsidiaries in Canada and the UK for regulatory compliance and distribution. In late 2024, the company secured a $25 million Series B funding round led by HealthTech Ventures to accelerate FDA clearance for its next-generation glucose monitor; it also announced a strategic partnership with Medtronic in Q3 2025 for integration into hospital IoT systems and acquired BioSense Analytics to enhance AI-driven predictive algorithms. These developments mark NIMU's expansion into enterprise health systems and international markets, including pilot programs in Asia.